Is pancreatic polypeptide response to food ingestion a reliable index of vagal function in type 1 diabetes?

References

• Anonymous. Report and recommendations of the San Antonio conference on diabetic neuropathy. Neurology 1988; 38: 1161–5
   PubMedGoogle Scholar
• Concensus Statement. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Neurology 1992; 42: 1823–39
   PubMedGoogle Scholar
• Hilsted J. Testing for autonomic neuropathy. Ann Clin Res 1984; 16: 128–35
   PubMedGoogle Scholar
• Hilsted J., Low P. A. Diabetic autonomic neuropathy. Clinical autonomic disorders. 2nd ed, P. A Low. Lippincott‐Raven, Philadelphia, New York 1997; 487–509
   Google Scholar
• Krarup T., Schwartz T. W., Hilsted J., Madsbad S., Verlaege O., Sestoft L. Impaired response of pancreatic polypeptide to hypoglycemia: an early sign of autonomic neuropathy in diabetics. Br Med J (Clin Res) 1979; 2: 1544–6
   PubMedGoogle Scholar
• Levitt N. S., Vinik Al., Sive A. A., Van Tonder S., Lund A. Impaired pancreatic polypeptide responses to insulin‐induced hypoglycemia in diabetic autonomic neuropathy. J Clin Endocrinol Metab 1980; 50: 445–9
   PubMed Web of Science ®Google Scholar
• Hilsted J., Madsbad S., Krarup T., Tronier B., Galbo H., Sestoft L., et al. No response of pancreatic hormones to hypoglycemia in diabetic autonomic neuropathy. J Clin Endocrinol Metab 1982; 54: 815–9
   PubMedGoogle Scholar
• Gambardella S., Felici M. G., Annibale B., Fave G. F. D., Jacoangeli F., Spallone V., et al. Pancreatic polypeptide response to a protein‐rich meal in diabetic patients with and without neuropathy. J Endocrinol Invest 1986; 9: 1–4
   PubMedGoogle Scholar
• Hossdorf T., Wagner M., Heppe H. E. Pancreatic polypeptide (PP) response to food in type 1 diabetics with and without diabetic autonomic neuropathy. Hepato‐gastroenterology 1988; 35: 238–41
   PubMedGoogle Scholar
• Rasmussen M. H., Carstensen H., List S., Schwartz T. W., Hilsted J. Impaired pancreatic polypeptide response to a meal in type 1 diabetic patients: vagal neuropathy or islet cell dysfunction?. Acta Endocrinol 1995; 128: 221–4
   Google Scholar
• Schwartz T. W., Stadil F., Chance R. E., Rehfeld J. F., Larson L‐I., Moon N. E. Pancreatic‐polypeptide response to food in duodenal‐ulcer patients before and after vagotomy. Lancet 1976; 7969: 1102–5
   Google Scholar
• Taylor I. L., Impicciatore M., Carter D. C., Walsh J. H. Effect of atropine and vagotomy on pancreatic polypeptide response to a meal in dogs. Am J Physiol 1978; 235: E443–7
   PubMedGoogle Scholar
• Lovgren N. A., Poulsen J., Schwartz T. W. Impaired pancreatic innervation after selective gastric vagotomy. Reduction of the pancreatic polypeptide response to food and insulin hypoglycemia. Scand J Gastroenterol 1981; 16: 811–6
   PubMed Web of Science ®Google Scholar
• Cryer P. E. Hypoglycemia‐associated autonomic failure. Hypoglycemia and diabetes. Clinical and physiological aspects. 1st ed, B. M Frier, B. M Fischer. Edward Arnold, London 1993; 275–83
   Google Scholar
• Damholt M. B., Rasmussen B. K., Hilsted L., Jensen R., Hilsted J. Basal serum pancreatic polypeptide is dependent on age and gender in a normal polulation. Scand J Clinical Invest 1997; 57: 695–702
   PubMed Web of Science ®Google Scholar
• Ewing D. J., Bellavere F., Espi F., McKibben B. M., Buchanan K. D., Riemersma R. A., et al. Correlation of cardiovascular and neuroendocrine tests of autonomic function in diabetes. Metabolism 1986; 35: 349–53
   PubMedGoogle Scholar
• Leveston S. A., Shah S. D., Cryer P. E. Cholinergic stimulation of norepinephrine release in man. Evidence of a sympathetic postganglionic axonal lesion in diabetic adrenergic neuropathy. J Clin Invest 1979; 64: 374–80
   PubMed Web of Science ®Google Scholar
• Matthews D. M., Martyn C. N., Riemersma R. A., Clarke B. F., Ewing D. J. Noradrenaline response to edrophonium (Tensilon) and its relation to other autonomic tests in diabetic subjects. Diabetes Res 1987; 6: 175–80
   PubMedGoogle Scholar
• Vernino S., Low P. A., Fealy R. D., Stewart J. D., Farrugia G., Lemon V. A. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000; 343: 847–55
   PubMed Web of Science ®Google Scholar
• Hermansen K., Schwartz T. W. The influence of calcium on the basal and acetylcholine‐stimulated secretion of pancreatic polypeptide. Endocrinology 1979; 105: 1469–74
   PubMedGoogle Scholar
• Holst J. J., Jensen S. L., Nielsen O. V., Schwartz T. W. Oxygen supply, oxygen consumption, and endocrine and exocrine secretion of the isolated, perfused porcine pancreas. Acta Physiol Scand 1980; 109: 7–13
   PubMedGoogle Scholar
• Silvestre R. A., Miralles P., Monge L., Villanueva M. L., Marco J. Inhibitory effect of galanin on pancreatic polypeptide release by the perfused rat pancreas. Life Sci 1987; 40: 1829–33
   PubMedGoogle Scholar
• Weir G. C., Samols E., Loo S., Patel Y. C., Gabbay K. H. Somatostatin and pancreatic polypeptide secretion: effects of glucagon, insulin, and arginine. Diabetes 1979; 28: 35–40
   PubMedGoogle Scholar
• Floyd J. C Jr., Fajans S. S., Pek S. Regulation in healthy subjects of the secretion of human pancreatic polypeptide. A newly recognized pancreatic islet polypeptide. Trans Assoc Am Physicians 1977; 89: 146–58
   Google Scholar
• Larsen S., Hilsted J., Tronier B., Worning H. Pancreatic hormone secretion in chronic pancreatitis without residual beta‐cell function. Acta Endocrinol 1988; 118: 357–64
   PubMedGoogle Scholar
• Marco J., Hedo J. A., Villanueva M. L. Control of pancreatic polypeptide secretion by glucose in man. J Clin Endocrinol Metab 1978; 46: 140–5
   PubMed Web of Science ®Google Scholar
• Tsuda K., Seino Y., Mori K., Seino S., Takemura J., Kuzuya H., et al. Hyperfunction of the entero‐PP axis in non‐insulin dependent diabetes mellitus. Horm Metab Res 1983; 15: 581–5
   PubMed Web of Science ®Google Scholar
• Floyd J. C Jr. Pancreatic polypeptide. Clin Gastroenterol 1980; 9: 657–78
   PubMedGoogle Scholar
• Adrian T. E., Besterman H. S., Cooke T. J. C., Bloom S. R., Barnes A. J., Russel R. C. G. Mechanism of pancreatic polypeptide release in man. Lancet 1977; 22: 161–3
   Google Scholar
• Lugari R., Gnudi A., Dall'argine P., Vattini A., Rignanese G., Dall'aglio B., et al. Diabetic autonomic neuropathy and impaired human pancreatic polypeptide secretion in response to food. J Clin Endocrinol Metab 1987; 64: 279–82
   PubMed Web of Science ®Google Scholar
• Schwartz T. W. Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 1983; 85: 1411–25
   PubMed Web of Science ®Google Scholar
• Taylor I. L., Feldman M., Richardson C. T., Walsh J. H. Gastric and cephalic stimulation of pancreatic polypeptide release. Gastroenterology 1978; 75: 432–7
   PubMed Web of Science ®Google Scholar
• Track N. S., McLeod R. S., Mee A. V. Human pancreatic polypeptide: studies of fasting and postprandial plasma concentrations. Can J Physiol Pharmacol 1980; 58: 1484–9
   PubMed Web of Science ®Google Scholar
• Greenberg G. R., Adrian T. E., Baron J. H., McCloy R. F., Chadwick V. S., Bloom S. R. Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet 1978; 16: 1280–2
   Google Scholar
• Spitz I. M., Zylber E., Leroith D. Atropine suppression of basal and metoclopramide‐induced human pancreatic polypeptide secretion in man. Metabolism 1979; 28: 527–30
   PubMed Web of Science ®Google Scholar